121 related articles for article (PubMed ID: 38241634)
1. Life Expectancy After Treatment of Metastatic Bone Disease: An International Trend Analysis.
Rogers DL; Raad M; Rivera JA; Wedin R; Laitinen M; Sørensen MS; Petersen MM; Hilton T; Morris CD; Levin AS; Forsberg JA
J Am Acad Orthop Surg; 2024 Mar; 32(6):e293-e301. PubMed ID: 38241634
[TBL] [Abstract][Full Text] [Related]
2. Patient survival following joint replacement due to metastatic bone disease - comparison of overall patient and prostheses survival between cohorts treated in two different time-periods.
Hovgaard TB; Horstmann PF; Petersen MM; Sørensen MS
Acta Oncol; 2018 Jun; 57(6):839-848. PubMed ID: 29293034
[TBL] [Abstract][Full Text] [Related]
3. Communication in surgical decision-making while managing metastatic bone disease: matching patient expectations with surgical goals.
Barton KI; Hazenbiller O; Freeman G; Kashluba K; Ball M; Aboutaha A; Puloski SKT; Monument MJ
Support Care Cancer; 2021 Feb; 29(2):1111-1119. PubMed ID: 32607597
[TBL] [Abstract][Full Text] [Related]
4. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
5. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
8. Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?
Gutowski CJ; Zmistowski B; Fabbri N; Boland PJ; Healey JH
Clin Orthop Relat Res; 2019 Apr; 477(4):707-714. PubMed ID: 30811363
[TBL] [Abstract][Full Text] [Related]
9. Is High-dose Radiation Therapy Associated With Early Revision Due to Aseptic Loosening in Patients With a Sarcoma of the Lower Extremities Reconstructed With a Cemented Endoprosthesis?
Arnold MT; Geiger EJ; Hart C; Greig D; Trikha R; Sekimura T; Eckardt JJ; Bernthal NM
Clin Orthop Relat Res; 2023 Mar; 481(3):475-487. PubMed ID: 35977001
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic and insurance-related disparities in disease-specific survival among patients with metastatic bone disease.
Jawad MU; Pollock BH; Wise BL; Zeitlinger LN; O' Donnell EF; Carr-Ascher JR; Cizik A; Ferrell B; Thorpe SW; Randall RL
J Surg Oncol; 2023 Jan; 127(1):159-173. PubMed ID: 36121418
[TBL] [Abstract][Full Text] [Related]
11. Life expectancy in pancreatic neuroendocrine cancer.
Brooks JC; Shavelle RM; Vavra-Musser KN
Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):88-97. PubMed ID: 30220478
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.
Errani C; Cosentino M; Ciani G; Ferra L; Alfaro PA; Bordini B; Donati DM
Int Orthop; 2021 May; 45(5):1337-1346. PubMed ID: 33392682
[TBL] [Abstract][Full Text] [Related]
13. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal survival trends of patients with cancer with surgically managed appendicular metastatic bone disease: systematic review.
Abbott A; Kendal JK; Hewison C; Puloski S; Monument M
Can J Surg; 2021; 64(6):E550-E560. PubMed ID: 34728520
[TBL] [Abstract][Full Text] [Related]
15. Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancy.
Frees SK; Kamal MM; Nestler S; Levien PM; Bidnur S; Brenner W; Thomas C; Jaeger W; Thüroff JW; Roos FC
Int J Urol; 2019 Mar; 26(3):385-390. PubMed ID: 30588677
[TBL] [Abstract][Full Text] [Related]
16. Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease.
Nooh A; Goulding K; Isler MH; Mottard S; Arteau A; Dion N; Turcotte R
Clin Orthop Relat Res; 2018 Mar; 476(3):535-545. PubMed ID: 29529637
[TBL] [Abstract][Full Text] [Related]
17. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
Sørensen MS; Gerds TA; Hindsø K; Petersen MM
Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
[TBL] [Abstract][Full Text] [Related]
18. Improved Survival After Multimodal Approach with
Wu D; Gomes Lima CJ; Moreau SL; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2019 Jul; 29(7):971-978. PubMed ID: 31017051
[No Abstract] [Full Text] [Related]
19. Factors Affecting Life Expectancy After Bone Metastasis in Adults - Results of a 5-year Prospective Study.
Zacharia B; Joy J; Subramaniam D; Pai PK
Indian J Surg Oncol; 2021 Dec; 12(4):759-769. PubMed ID: 35110900
[TBL] [Abstract][Full Text] [Related]
20. Development of a scoring system for survival following surgery for metastatic bone disease.
Baumber R; Gerrand C; Cooper M; Aston W
Bone Joint J; 2021 Nov; 103-B(11):1725-1730. PubMed ID: 34719268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
